Orient Pharma Co., Ltd.(TW:4166)
NT$22.55+0.05 (+0.22%)
TW:4166
Orient Pharma Co., Ltd. Revenue
NT$22.55
At close:+0.05 (+0.22%)
Orient Pharma Co., Ltd. (4166) Revenue
Orient Pharma Co., Ltd. Revenue
Orient Pharma Co., Ltd. had a revenue of 427.08M in the quarter ending Jun 30, 2026, with 28.94%. This bring the company's revenue in the last twelve months to 1.52B, Increased 7.18%. In the fiscal year ending Dec 31, 2025, Orient Pharma Co., Ltd. had annual revenue of 1.40B with 14.52% growth.
- Revenue (ttm)
- 1.52B
- Revenue Growth
- ―
- P/S Ratio
- 3.90
- Revenue/Employee
- TWD 8,094,671
- Employees
- 173
- Market Cap
- TWD 5.47B
Revenue Chart
Orient Pharma Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.40B | 177.56M | 14.52% |
| Dec 31, 2024 | 1.22B | 332.90M | 37.41% |
| Dec 31, 2023 | 889.91M | 378.05M | 73.86% |
| Dec 31, 2022 | 511.86M | 48.52M | 10.47% |
| Dec 31, 2021 | 463.34M | 51.33M | 12.46% |
| Dec 31, 2020 | 412.01M | 58.47M | 16.54% |
| Dec 31, 2019 | 353.54M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.